Pericardial Cytokine “Storm” in a COVID-19 Patient: the Confirmation of a Hypothesis

被引:0
|
作者
Cristian Deana
Luigi Vetrugno
Martina Fabris
Francesco Curcio
Emanuela Sozio
Carlo Tascini
Flavio Bassi
机构
[1] Academic Hospital of Udine,Department of Anesthesia and Intensive Care Medicine
[2] University of Udine,Department of Medicine
[3] Academic Hospital of Udine,Institute of Clinical Pathology, Department of Laboratory Medicine
[4] Udine University Hospital,Infectious Diseases Clinic
来源
Inflammation | 2022年 / 45卷
关键词
COVID-19; cardiac tamponade; cytokines; pericardial drainage; echocardiography; immunoglobulin test anti SARS–CoV–2;
D O I
暂无
中图分类号
学科分类号
摘要
Novel Coronavirus Disease in most cases produces mild symptoms which resolve after a few days. Some authors hypothesized that SARS-CoV-2 infection could trigger excessive cytokine production leading to a severe multi-organ disease requiring intensive care admission. Respiratory and neurological symptoms are the most frequently reported manifestation of the disease. Indeed, cardiac involvement is reported mostly as a part of a systemic disease. Few isolated cardiac manifestations of COVID-19 infection have been described. We report herein a case of SARS-CoV-2 related severe isolated pericardial involvement requiring ICU admission due to cardiac tamponade needing urgent drainage. Analysis of pericardial fluid from drainage demonstrated a higher cytokine concentration than blood values. Other causes of pericardial disease, such as autoimmunity, bacterial or other than COVID-19 infection, neoplasms or acute myocardial infarction were also evaluated, but all tests confirmed negative results. The suspicion of isolated involvement of the pericardium was therefore demonstrated by the analysis of cytokines which strongly support our hypothesis.
引用
收藏
页码:1 / 5
页数:4
相关论文
共 50 条
  • [41] Can tocilizumab calm the cytokine storm of COVID-19?
    Schulert, Grant S.
    LANCET RHEUMATOLOGY, 2020, 2 (08): : E449 - E451
  • [42] Candesartan could ameliorate the COVID-19 cytokine storm
    Elkahloun, Abdel G.
    Saavedra, Juan M.
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
  • [43] Cytokine storm in COVID-19 and parthenolide: Preclinical evidence
    Bahrami, Mohsen
    Kamalinejad, Mohammad
    Latifi, Seied Amirhossein
    Seif, Farhad
    Dadmehr, Majid
    PHYTOTHERAPY RESEARCH, 2020, 34 (10) : 2429 - 2430
  • [44] In reply-The "Perfect Cytokine Storm" of COVID-19
    Vijayvargiya, Prakhar
    Garrigos, Zerelda Esquer
    Almeida, Natalia E. Castillo
    Gurram, Pooja R.
    Stevens, Ryan W.
    Razonable, Raymund R.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (09) : 2037 - 2038
  • [45] Neurological Presentations in Patients with COVID-19 in Cytokine Storm
    Tutal Gursoy, Gorkem
    Yuksel, Hatice
    Mulkem Simsek, Inci
    Oral, Saniye
    Erdogan Kucukdagli, Fadime
    Karaman, Ayberk
    Akinci, Esragul
    Bastug, Aliye
    Guner, Hatice Rahmet
    Bektas, Hesna
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2023, 50 (01) : 89 - 95
  • [46] Weathering the Cytokine Storm in COVID-19: Therapeutic Implications
    Iannaccone, Giulia
    Scacciavillani, Roberto
    Del Buono, Marco Giuseppe
    Camilli, Massimiliano
    Ronco, Claudio
    Lavie, Carl J.
    Abbate, Antonio
    Crea, Filippo
    Massetti, Massimo
    Aspromonte, Nadia
    CARDIORENAL MEDICINE, 2020, 10 (05) : 277 - 287
  • [47] COVID-19: pressure ulcers, pain and the cytokine storm
    Gefen, Amit
    Ousey, Karen
    JOURNAL OF WOUND CARE, 2020, 29 (10) : 540 - 542
  • [48] The cytokine storm of COVID-19: a spotlight on prevention and protection
    Pearce, Lucie
    Davidson, Sean M.
    Yellon, Derek M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (08) : 723 - 730
  • [49] Tackling the cytokine storm in COVID-19, challenges and hopes
    Abdin, Shifaa M.
    Elgendy, Sara M.
    Alyammahi, Shatha K.
    Alhamad, Dima W.
    Omar, Hany A.
    LIFE SCIENCES, 2020, 257
  • [50] Hypoxemia and Cytokine Storm in COVID-19: Clinical Implications
    Aguero-Martinez, Calixto
    Gonzalez-Quevedo, Alina
    MEDICC REVIEW, 2021, 23 (3-4) : 54 - 59